January 2002
145
(Mϩ). HR-MS m/z: 221.0851 (Calcd for C15H11NO: 221.0841).
(1H, s), 6.58 (1H, d, Jϭ1.6 Hz), 6.59—6.60 (1H, m), 7.07—7.20 (2H, m),
7.33 (1H, d, Jϭ7.4 Hz), 7.39 (1H, d, Jϭ1.6 Hz), 7.59 (1H, d, Jϭ7.4 Hz),
8.32 (1H, br). MS m/z 223 (Mϩ). HR-MS m/z: 223.0977 (Calcd for
C15H13NO: 223.0997).
References
1) Ito C., Furukawa H., Chem. Pharm. Bull., 38, 1548—1550 (1990).
2) Timári G., Soós T., Hajós G., Messmer A., Nacsa J., Molnár J., Bioorg.
Med. Chem. Lett., 6, 2831—2836 (1996).
3-(2-Aminophenylethynyl)-2-isopropenylfuran (8): Pale yellow viscous
1
oil (70 mg, 33%). IR (neat) cmϪ1: 3445, 3381, 2206. H-NMR (CDCl3) d:
3) a) Soós T., Timári G., Hajós G., Tetrahedron Lett., 40, 8607—8609
(1999); b) Hagiwara H., Choshi T., Fujimoto H., Sugino E., Hibino S.,
Chem. Pharm. Bull., 46, 1948—1949 (1998); c) Hagiwara H., Choshi
T., Nobuhiro J., Fujimoto H., Hibino S., ibid., 49, 881—886 (2001); d)
Beccalli E. M., Clerici F., Marchesini A., Tetrahedron, 54, 11675—
11682 (1998).
4) a) Knölker H. J., Fröhner W., Tetrahedron Lett., 37, 9183—9186
(1996); b) Idem, Synthesis, 2000, 2131—2136.
5) Yasuhara A., Kanamori Y., Kaneko M., Numata A., Kondo Y.,
Sakamoto T., J. Chem. Soc., Perkin Trans. 1, 1999, 529—534.
6) Snieckus V., Chem. Rev., 90, 879—933 (1990).
7) Sonogashira K., Ohda Y., Hagihara N., Tetrahedron Lett., 1975,
4467—4470.
8) Sakamoto T., Kondo Y., Iwashita S., Nagano T., Yamanaka H., Chem.
Pharm. Bull., 36, 1305—1308 (1988).
9) Koyanagi J., Yamamoto K., Nakayama K., Tanaka A., J. Heterocycl.
Chem., 32, 1289—1291 (1995).
10) Shin K., Ogasawara K., Synlett, 1995, 859—860.
2.23 (3H, s), 4.22 (2H, br), 5.13 (1H,s), 5.88 (1H, s), 6.49 (1H, d, Jϭ1.9 Hz),
6.68—6.73 (2H, m), 7.13 (1H, dt, Jϭ1.6, 6.6 Hz), 7.30—7.33 (2H, m). MS
m/z 223 (Mϩ). HR-MS m/z: 223.1012 (Calcd for C15H13NO: 223.0997).
The Protection of 8 with Ethyl Chloroformate A mixture of 8 (28 mg,
1.26 mmol), ethyl chloroformate (164 mg, 1.51 mmol), and pyridine (5 ml)
was stirred for 3 h at room temperature, and concentrated. Water (50 ml) was
added to the residue, and extracted with Et2O (50 mlϫ3). The ethereal layer
was washed with CuSO4·5H2O (50 mlϫ2) and water (100 mlϫ2). The
residue obtained from the extract was purified by silica gel column chro-
matography (hexane) to give 5 as a yellow viscous oil (283 mg, 76%).
Furostifoline (1)1) A mixture of 7 (23 mg, 0.10 mmol), a catalytic
amount of I2, and toluene (10 ml) was irradiated for 30 min. The residue ob-
tained from the mixture was purified by silica gel column chromatography
(AcOEt : hexaneϭ1 : 20). Colorless prisms from hexane (5.6 mg, 24%). mp
175—176 °C (lit.4b) 174—175 °C). IR (KBr) cmϪ1: 3406, 1457, 1442, 1360,
1
1308, 1159, 1043, 878, 746, 735. H-NMR (CDCl3) d: 2.68 (3H, s), 7.00
(1H, d, Jϭ2.2 Hz), 7.23—7.28 (1H, m), 7.38 (1H, t, Jϭ8.2 Hz), 7.49 (1H, d,
Jϭ8.2 Hz), 7.73 (1H, d, Jϭ2.2 Hz), 7.77 (1H, s), 8.06 (1H, d, Jϭ8.2 Hz),
8.28 (1H, br). UV l (MeOH) nm: 260, 278, 295, 322, 334. MS m/z 221